Evaluation of the effect of plant compounds extract (including aqueous extract of Ador-Cancer, saffron petals and mountain tea) in patients with coronary disease

INTERVENTION: Intervention 1: Intervention group: Patients with Covid‐19 will consume 10 ml of syrup containing aqueous extracts of Ador‐Cancer, saffron petals and mountain tea 3 times a day. In this study, no special equipment is used and the explanations of this trial are given in printed form to the volunteers. Entry to this study does not require special training. Herbal extract syrup is prepared and approved in Rafsanjan University of Medical Sciences. Intervention 2: Control group: Control group: Yamaran with Covid‐19 will take 10 ml of placebo 3 times a day. In this study, no special equipment is used and the explanations of this trial are given in printed form to the volunteers. Entry to this study does not require special training. The placebo is prepared and approved at Rafsanjan University of Medical Sciences. CONDITION: symptoms of COVID‐19 patients. ; COVID‐19, virus identified U07.1 PRIMARY OUTCOME: The length of hospitalization of patients with Covid‐19. Timepoint: 21 days after starting of intervention. Method of measurement: By referring to the patient's medical record. The mortality in patients with Covid‐19. Timepoint: 21 days after starting of intervention. Method of measurement: By referring to the patient's medical record. The pulmonary infiltration in patients with Covid‐19. Timepoint: 7, 14 and 21 days after starting of intervention. Method of measurement: With CT scan. SECONDARY OUTCOME: Side effects from the use of herbal compounds (COVID‐herbs). Timepoint: 7, 14 and 21 days after starting of intervention. Method of measurement: Refer to the medical file and complete a special questionnaire for complications. The kidney function in patients with Covid‐19. Timepoint: 7, 14 and 21 days after starting of intervention. Method of measurement: Evaluation of chemical parameters such as BUN and Creatinine by colorimetric method with autoanalyzer. The liver function in patients with Covid‐19. Timepoint: 7, 14 and 21 days after starting of intervention. Method of measurement: Evaluation of SGOT and SGPT enzymes using ELISA kit. INCLUSION CRITERIA: Inclusion criteria in this study include all patients who have been diagnosed with Covid 19 infection and do not have other infections or diseases such as influenza, pulmonary insufficiency, ARDS pneumonia and other cold symptoms, as well as files with complete data. Consciously taken from patients.